Nanoparticles show potential for halting inflammation and scarring in alcohol-related liver disease

Across the world, more than 1.5 billion people suffer from chronic liver disease. The U.S. Centers for Disease Control and Prevention reports that it kills more than 52,000 people a year in the United States alone—the ninth most common cause of death in the nation.